{"page":"https://casescribe.ai/explorer/regulation-changes/2018-12-03","generated_at":"2026-10-03T18:29:53.439Z","data_as_of":{"decisions":944125,"first_year":2017,"last_year":2026,"latest_decision":"2026-04-30","cfr":"2026-10-01","m21":"2026-09-29"},"about":{"publisher":"CaseScribe AI (VA Law Explorer)","source":"Public Board of Veterans' Appeals decisions (appeals of VA decisions, not VA's first decisions), M21-1 Adjudication Procedures Manual, 38 CFR Parts 3 and 4.","method":"Outcomes are issue-level: each condition the Board decided in a decision counts once. Decision data is extracted by AI and can contain errors. Rates describe past appeals and do not predict any claim.","disclaimer":"For research only. CaseScribe AI is not a law firm and this is not legal advice. Verify figures against the source decisions and regulations.","attribution":"Cite as: VA Law Explorer, CaseScribe AI, with the page URL."},"data":{"week_of":"2018-12-03","changes":[{"source":"38 CFR","section":"Schedule of ratings - hemic and lymphatic systems.","date":"2018-12-09","url":"https://www.ecfr.gov/current/title-38/section-4.117","formatting_only":false,"added":["7702 Agranulocytosis, acquired:","Requiring bone marrow transplant;","or infections recurring, on average, at least once every six weeks per 12-month period | 100","Requiring intermittent myeloid growth factors (granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) or continuous immunosuppressive therapy such as cyclosporine to maintain absolute neutrophil count (ANC) greater than 500/microliter (µl) but less than 1000/µl;","or infections recurring, on average, at least once every three months per 12-month period | 60","Requiring intermittent myeloid growth factors to maintain ANC greater than 1000/µl;","or infections recurring, on average, at least once per 12-month period but less than once every three months per 12-month period | 30","Requiring continuous medication (e.g., antibiotics) for control;"],"removed":["Link to an amendment published at 83 FR 54254, Oct.","29, 2018.","Link to a correction published at 83 FR 54881, Nov.","1, 2018.","7700 Anemia, hypochromic-microcytic and megaloblastic, such as iron-deficiency and pernicious anemia:","Hemoglobin 5gm/100ml or less, with findings such as high output congestive heart failure or dyspnea at rest | 100","Hemoglobin 7gm/100ml or less, with findings such as dyspnea on mild exertion, cardiomegaly, tachycardia (100 to 120 beats per minute) or syncope (three episodes in the last six months) | 70","Hemoglobin 8gm/100ml or less, with findings such as weakness, easy fatigability, headaches, lightheadedness, or shortness of breath | 30"]}]}}